IRIS Accounts Production v24.3.2.46 13735592 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure137355922023-03-31137355922024-03-31137355922023-04-012024-03-31137355922021-11-09137355922021-11-102023-03-31137355922023-03-3113735592ns16:EnglandWales2023-04-012024-03-3113735592ns15:PoundSterling2023-04-012024-03-3113735592ns11:Director12023-04-012024-03-3113735592ns11:PrivateLimitedCompanyLtd2023-04-012024-03-3113735592ns11:SmallEntities2023-04-012024-03-3113735592ns11:AuditExemptWithAccountantsReport2023-04-012024-03-3113735592ns11:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3113735592ns11:SmallCompaniesRegimeForAccounts2023-04-012024-03-3113735592ns11:FullAccounts2023-04-012024-03-311373559212023-04-012024-03-3113735592ns11:Director22023-04-012024-03-3113735592ns11:Director32023-04-012024-03-3113735592ns11:Director42023-04-012024-03-3113735592ns11:CompanySecretary12023-04-012024-03-3113735592ns11:RegisteredOffice2023-04-012024-03-3113735592ns6:CurrentFinancialInstruments2024-03-3113735592ns6:CurrentFinancialInstruments2023-03-3113735592ns6:Non-currentFinancialInstruments2024-03-3113735592ns6:Non-currentFinancialInstruments2023-03-3113735592ns6:ShareCapital2024-03-3113735592ns6:ShareCapital2023-03-3113735592ns6:RetainedEarningsAccumulatedLosses2024-03-3113735592ns6:RetainedEarningsAccumulatedLosses2023-03-3113735592ns6:NetGoodwill2023-04-012024-03-3113735592ns6:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113735592ns6:FurnitureFittings2023-04-012024-03-3113735592ns6:MotorVehicles2023-04-012024-03-3113735592ns6:ComputerEquipment2023-04-012024-03-3113735592ns6:NetGoodwill2023-03-3113735592ns6:NetGoodwill2024-03-3113735592ns6:NetGoodwill2023-03-3113735592ns6:FurnitureFittings2023-03-3113735592ns6:MotorVehicles2023-03-3113735592ns6:ComputerEquipment2023-03-3113735592ns6:FurnitureFittings2024-03-3113735592ns6:MotorVehicles2024-03-3113735592ns6:ComputerEquipment2024-03-3113735592ns6:FurnitureFittings2023-03-3113735592ns6:MotorVehicles2023-03-3113735592ns6:ComputerEquipment2023-03-3113735592ns6:WithinOneYearns6:CurrentFinancialInstruments2024-03-3113735592ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3113735592ns6:WithinOneYearns6:CurrentFinancialInstrumentsns6:HirePurchaseContracts2024-03-3113735592ns6:WithinOneYearns6:CurrentFinancialInstrumentsns6:HirePurchaseContracts2023-03-3113735592ns6:WithinOneYear2024-03-3113735592ns6:WithinOneYear2023-03-3113735592ns6:BetweenOneFiveYears2024-03-3113735592ns6:BetweenOneFiveYears2023-03-3113735592ns6:AllPeriods2024-03-3113735592ns6:AllPeriods2023-03-3113735592ns6:Secured2024-03-3113735592ns6:Secured2023-03-31
REGISTERED NUMBER: 13735592 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

Jaunty Healthcare Limited

Jaunty Healthcare Limited (Registered number: 13735592)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 5


Jaunty Healthcare Limited

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Mr Garry Myers
Mrs Tracy Ann Ward
Mr Crispin Patrick Roland Bliss
Mrs Rosalyn Diana Myers



SECRETARY: Mrs Tracy Ann Ward



REGISTERED OFFICE: Jaunty Springs Health Centre
53 Jaunty Way
Sheffield
South Yorkshire
S12 3DZ



REGISTERED NUMBER: 13735592 (England and Wales)



ACCOUNTANTS: Landin Wilcock & Co
Chartered Accountants
68 Queen Street
Sheffield
South Yorkshire
S1 1WR



BANKERS: Natwest
PO Box 120
42 High Street
Sheffield
South Yorkshire
S1 2GE



SOLICITORS: Norrie Waite & Slater
9-12 East Parade
Sheffield
S1 2ET

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Jaunty Healthcare Limited


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Directors' Report are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Jaunty Healthcare Limited for the year ended 31 March 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Jaunty Healthcare Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Jaunty Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of Jaunty Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Jaunty Healthcare Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Jaunty Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Jaunty Healthcare Limited. You consider that Jaunty Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Jaunty Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Landin Wilcock & Co
Chartered Accountants
68 Queen Street
Sheffield
South Yorkshire
S1 1WR


24 March 2025

Jaunty Healthcare Limited (Registered number: 13735592)

Balance Sheet
31 March 2024

31/3/24 31/3/23
Notes £    £   
FIXED ASSETS
Intangible assets 4 1,881,423 1,881,423
Tangible assets 5 18,551 23,894
Investment property 6 55,000 55,000
1,954,974 1,960,317

CURRENT ASSETS
Stocks 66,083 75,509
Debtors 7 271,868 256,412
Cash at bank and in hand 4,246 8,085
342,197 340,006
CREDITORS
Amounts falling due within one year 8 (429,963 ) (458,467 )
NET CURRENT LIABILITIES (87,766 ) (118,461 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,867,208 1,841,856

CREDITORS
Amounts falling due after more than one
year

9

(235,432

)

(164,016

)
NET ASSETS 1,631,776 1,677,840

CAPITAL AND RESERVES
Called up share capital 1,575,000 1,575,000
Retained earnings 56,776 102,840
1,631,776 1,677,840

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Jaunty Healthcare Limited (Registered number: 13735592)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 March 2025 and were signed on its behalf by:





Mrs Tracy Ann Ward - Director


Jaunty Healthcare Limited (Registered number: 13735592)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

Jaunty Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going Concern

The financial statements have been prepared on a going concern basis.

During the period the company made an actual trading loss and has net current liabilities. The directors are however confident that measures will be introduced in the industry as a whole to improve the situation and in the meantime they will continue to provide the necessary financial support as required.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Jaunty Healthcare Limited (Registered number: 13735592)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued

Goodwill
Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition.

Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Goodwill is amortised over its useful economic life, save as its residual value exceeds cost.

NHS Licences

When the company acquires a trading pharmacy, an element of the excess of the fair value of the consideration given over the fair value of the identifiable assets and liabilities acquired relates to the NHS licence, representing the consideration paid to acquire the rights to sell prescribed drugs in those retail outlets. The value of the NHS licence at the date of acquisition is based on an assessment by the directors of the present value of future cash flows resulting from NHS turnover for each outlet.

The NHS licence does not attach to the specific freehold or leasehold property and exists in perpetuity. Accordingly, the directors consider that most NHS licences have indefinite useful economic lives and no amortisation is charged unless the directors anticipate exiting a pharmacy location. The annual NHS contract is subject to annual impairment tests.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class Amortisation method and rate

NHS licences 20 years straight line.

As the residual value of NHS licences is in excess of its carrying value, no amortisation has been charged.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 20% on reducing balance

Tangible fixed assets are initially measured at cost. Subsequently, they are measured at cost less accumulated depreciation and impairment losses

Jaunty Healthcare Limited (Registered number: 13735592)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Financial assets and financial liabilities are recognised when the company becomes party to the contractual provisions of the instrument. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the asset of the company after deducting all of its liabilities.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 25 (2023 - 26 ) .

Jaunty Healthcare Limited (Registered number: 13735592)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 1,881,423
NET BOOK VALUE
At 31 March 2024 1,881,423
At 31 March 2023 1,881,423

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2023 6,829 10,753 12,279 29,861
Additions - - 899 899
Disposals - (1,638 ) - (1,638 )
At 31 March 2024 6,829 9,115 13,178 29,122
DEPRECIATION
At 1 April 2023 1,252 2,464 2,251 5,967
Charge for year 1,029 1,757 2,193 4,979
Eliminated on disposal - (375 ) - (375 )
At 31 March 2024 2,281 3,846 4,444 10,571
NET BOOK VALUE
At 31 March 2024 4,548 5,269 8,734 18,551
At 31 March 2023 5,577 8,289 10,028 23,894

6. INVESTMENT PROPERTY

The property was transferred to Jaunty Healthcare Limited from Shires Pharmacies Limited at an agreed value of £55,000. The directors do not consider there has been any material change in this valuation as at 31 March 2024.

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/24 31/3/23
£    £   
Trade debtors 155,190 174,453
Other debtors 116,678 81,959
271,868 256,412

Jaunty Healthcare Limited (Registered number: 13735592)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/3/24 31/3/23
£    £   
Hire purchase contracts (see note 10) - 4,285
Trade creditors 196,379 238,659
Taxation and social security 9,519 10,566
Other creditors 224,065 204,957
429,963 458,467

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31/3/24 31/3/23
£    £   
Other creditors 235,432 164,016

10. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
31/3/24 31/3/23
£    £   
Net obligations repayable:
Within one year - 4,285

Non-cancellable operating leases
31/3/24 31/3/23
£    £   
Within one year 18,350 16,000
Between one and five years 55,050 64,000
73,400 80,000

Jaunty Healthcare Limited (Registered number: 13735592)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


11. SECURED DEBTS

The following secured debts are included within creditors:

31/3/24 31/3/23
£    £   
Other loans 193,252 120,438
Hire purchase contracts - 4,285
193,252 124,723

Loans from the G & A Property fund (the pension scheme of the directors Mr G & Mrs R D Myers) were made in the current and previous period. These loans have been secured by a fixed charge on the book debts of the company.

Hire purchase liabilities were secured on the associated assets.